• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在哮喘患者和健康对照者中,外周和中央气道的成纤维细胞中白细胞三烯受体的表达不同。

Leukotriene receptors are differently expressed in fibroblast from peripheral versus central airways in asthmatics and healthy controls.

机构信息

Respiratory Medicine and Allergology, Department of Clinical Sciences in Lund, Lund University, Lund, Sweden.

出版信息

Prostaglandins Leukot Essent Fatty Acids. 2011 Aug;85(2):67-73. doi: 10.1016/j.plefa.2011.04.025. Epub 2011 May 18.

DOI:10.1016/j.plefa.2011.04.025
PMID:21596548
Abstract

Leukotrienes are involved in airway inflammation, and are believed to stimulate airway remodeling in asthma. The aim of the project was to investigate the expression of leukotriene receptors in peripheral and central airway fibroblasts. Peripheral and central airway fibroblasts, from asthmatics and healthy controls, were investigated for the amount of cysteinyl-leukotriene receptors (CysLT(1) and CysLT(2)), leukotriene B(4) receptors (BLT(1) and BLT(2)), IL-13 receptor-α(1) (IL-13Rα(1)) and the IL-4 receptor (IL-4R). The mRNA expression of CysLT(1) in fibroblasts from peripheral airways was higher compared to central airways. There was no difference in CysLT(2) between peripheral and central airways. On the contrary, BLT(1) and BLT(2) were lower in fibroblasts from peripheral airways compared to central. The expression of CysLT(1) was higher than CysLT(2) in fibroblasts from peripheral airways, and the expression of BLT(1) was higher than BLT(2) in both peripheral and central airways. Both BLT(1) and BLT(2) were higher in asthmatics compared to healthy controls, while CysLT(1) and CysLT(2) did not differ. The expression of IL-13Rα(1) was higher in asthmatics compared to controls, and correlated to the BLTs. All fibroblasts stained for the different receptor proteins. Leukotriene receptors are differently expressed in fibroblasts from peripheral compared to central airways, which may explain a suggested cysteinyl-leukotriene driven remodeling mainly in the peripheral airways.

摘要

白三烯参与气道炎症,并被认为刺激哮喘中的气道重塑。该项目的目的是研究外周和中央气道成纤维细胞中白三烯受体的表达。从哮喘患者和健康对照者的外周和中央气道成纤维细胞中,研究了半胱氨酰白三烯受体(CysLT(1)和 CysLT(2))、白三烯 B(4)受体(BLT(1)和 BLT(2))、IL-13 受体-α(1)(IL-13Rα(1))和 IL-4 受体(IL-4R)的数量。与中央气道相比,外周气道成纤维细胞中 CysLT(1)的 mRNA 表达更高。外周和中央气道之间 CysLT(2)没有差异。相反,与中央气道相比,外周气道成纤维细胞中的 BLT(1)和 BLT(2)较低。外周气道成纤维细胞中 CysLT(1)的表达高于 CysLT(2),而 BLT(1)和 BLT(2)在外周和中央气道中的表达均高于 BLT(2)。与健康对照组相比,哮喘患者的 BLT(1)和 BLT(2)表达均升高,而 CysLT(1)和 CysLT(2)则无差异。与对照组相比,哮喘患者的 IL-13Rα(1)表达更高,并且与 BLTs 相关。所有成纤维细胞均对不同的受体蛋白进行染色。与中央气道相比,外周气道的成纤维细胞中白三烯受体的表达不同,这可能解释了一种建议的半胱氨酰白三烯驱动的重塑主要发生在外周气道。

相似文献

1
Leukotriene receptors are differently expressed in fibroblast from peripheral versus central airways in asthmatics and healthy controls.在哮喘患者和健康对照者中,外周和中央气道的成纤维细胞中白细胞三烯受体的表达不同。
Prostaglandins Leukot Essent Fatty Acids. 2011 Aug;85(2):67-73. doi: 10.1016/j.plefa.2011.04.025. Epub 2011 May 18.
2
The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.低剂量白三烯受体拮抗剂治疗对小鼠哮喘模型气道重塑和半胱氨酰白三烯表达的影响
Exp Mol Med. 2006 Apr 30;38(2):109-18. doi: 10.1038/emm.2006.14.
3
Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.半胱氨酰白三烯受体拮抗剂MK-571改变小鼠哮喘模型支气管肺泡灌洗液蛋白质组。
Eur J Pharmacol. 2007 Dec 1;575(1-3):134-41. doi: 10.1016/j.ejphar.2007.07.027. Epub 2007 Jul 24.
4
Leukotrienes and isocyanate-induced asthma: a pilot study.白三烯与异氰酸酯诱发的哮喘:一项初步研究。
Clin Exp Allergy. 2004 Nov;34(11):1684-9. doi: 10.1111/j.1365-2222.2004.02102.x.
5
International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions.国际基础和临床药理学联盟. LXXXIV: 白三烯受体命名法、分布和病理生理学功能。
Pharmacol Rev. 2011 Sep;63(3):539-84. doi: 10.1124/pr.110.004184.
6
Leukotriene modifiers for asthma treatment.哮喘治疗中的白三烯调节剂。
Clin Exp Allergy. 2010 Dec;40(12):1732-41. doi: 10.1111/j.1365-2222.2010.03630.x.
7
Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.半胱氨酰白三烯1型受体拮抗剂孟鲁司特与甲泼尼龙改善过敏性哮喘机制的比较研究
J Pharmacol Exp Ther. 2005 Feb;312(2):432-40. doi: 10.1124/jpet.104.074922. Epub 2004 Oct 6.
8
Localization and upregulation of cysteinyl leukotriene-1 receptor in asthmatic bronchial mucosa.半胱氨酰白三烯-1受体在哮喘支气管黏膜中的定位及上调
Am J Respir Cell Mol Biol. 2005 Dec;33(6):531-40. doi: 10.1165/rcmb.2005-0124OC. Epub 2005 Aug 25.
9
Leukotrienes, antileukotrienes and asthma.白三烯、抗白三烯与哮喘
Mini Rev Med Chem. 2008 Jun;8(7):647-56. doi: 10.2174/138955708784567395.
10
Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.孟鲁司特钠,半胱氨酰白三烯受体 1 拮抗剂,对博来霉素诱导的肺纤维化小鼠发病机制的影响。
Eur J Pharmacol. 2011 Jan 10;650(1):424-30. doi: 10.1016/j.ejphar.2010.09.084. Epub 2010 Oct 27.

引用本文的文献

1
Virus profiling of bronchoalveolar lavage fluid in hospitalized non-COVID-19 adult patients with pulmonary infection from November 2020 to November 2021.2020年11月至2021年11月住院的非新冠肺炎成年肺部感染患者支气管肺泡灌洗液的病毒谱分析
Virol Sin. 2025 Apr;40(2):166-175. doi: 10.1016/j.virs.2025.03.005. Epub 2025 Mar 20.
2
Expression of Stress-Induced Genes in Bronchoalveolar Lavage Cells and Lung Fibroblasts from Healthy and COPD Subjects.健康受试者和 COPD 患者支气管肺泡灌洗液细胞和肺成纤维细胞中应激诱导基因的表达。
Int J Mol Sci. 2024 Jun 15;25(12):6600. doi: 10.3390/ijms25126600.
3
Cysteinyl-leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics.
过敏性哮喘患者支气管灌洗与肺泡灌洗中半胱氨酰白三烯和前列腺素途径
Allergy. 2022 Aug;77(8):2549-2551. doi: 10.1111/all.15319. Epub 2022 Apr 28.
4
Recent Advances in Inflammation and Treatment of Small Airways in Asthma.哮喘中小气道炎症及治疗的最新进展
Int J Mol Sci. 2019 May 28;20(11):2617. doi: 10.3390/ijms20112617.
5
Expression, activity and localization of lysosomal sulfatases in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中溶酶体硫酸酯酶的表达、活性和定位。
Sci Rep. 2019 Feb 13;9(1):1991. doi: 10.1038/s41598-018-37958-w.
6
Endoplasmic reticulum, Golgi, and lysosomes are disorganized in lung fibroblasts from chronic obstructive pulmonary disease patients.慢性阻塞性肺疾病患者肺成纤维细胞中的内质网、高尔基体和溶酶体排列紊乱。
Physiol Rep. 2018 Mar;6(5). doi: 10.14814/phy2.13584.
7
Importance of the leukotriene B4-BLT1 and LTB4-BLT2 pathways in asthma.白三烯 B4-BLT1 和 LTB4-BLT2 途径在哮喘中的重要性。
Semin Immunol. 2017 Oct;33:44-51. doi: 10.1016/j.smim.2017.08.005.
8
Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease.硫酸酯酶修饰因子1(SUMF1)与慢性阻塞性肺疾病相关。
Respir Res. 2017 May 2;18(1):77. doi: 10.1186/s12931-017-0562-5.
9
Asthma phenotypes: the intriguing selective intervention with Montelukast.哮喘表型:孟鲁司特有趣的选择性干预
Asthma Res Pract. 2016 Aug 12;2:11. doi: 10.1186/s40733-016-0026-6. eCollection 2016.
10
Small airway dysfunction and bronchial asthma control : the state of the art.小气道功能障碍与支气管哮喘控制:现状
Asthma Res Pract. 2015 Dec 1;1:13. doi: 10.1186/s40733-015-0013-3. eCollection 2015.